Storia in 2 fonti

Three Biotech Stocks Stick Out With Their Stellar Charts

These biotech stocks all popped after their recent earnings reports. All three have outperformed 97% of stocks in the last 12 months.

Raccontata da

benzinga.com

investors.com

Confronto fonti

2 prospettive sulla stessa storia

AI · summaries

investors.comStai leggendo17 h fa

Three Biotech Stocks Stick Out With Their Stellar Charts

These biotech stocks all popped after their recent earnings reports. All three have outperformed 97% of stocks in the last 12 months.

originale

benzinga.com1 g fa

Biotech Is Booming, But These 2 Stocks Missed the Memo - Moderna (NASDAQ:MRNA), iShares Biotechnology ETF

Alnylam slashed 2026 guidance after initial Amvuttra surge from pent-up patients normalized; stock down 25% as real adoption missed Wall Street forecasts. Signal: pent-up demand can mask weaker fundamentals; sustained growth and pipeline maturity drive valuations more than launch hype.

Leggi questa versione →

Timeline cronologica

giovedì 20 agosto 2026·benzinga.com
Biotech Is Booming, But These 2 Stocks Missed the Memo - Moderna (NASDAQ:MRNA), iShares Biotechnology ETF
The iShares Biotechnology ETF is trading at new highs and 18 out of its top 20 constituents are green for the year.
venerdì 21 agosto 2026·investors.com
Three Biotech Stocks Stick Out With Their Stellar Charts
These biotech stocks all popped after their recent earnings reports. All three have outperformed 97% of stocks in the last 12 months.